Gene · 57167
Papers3,058
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,058
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39034804 | PubTator, text mining | PubMed |
| Diagnostic Value of SALL4 and OCT3/4 in Pediatric Testicular Tumors. | Diagnostics (Basel) | 2024 | 39001344 | PubTator, text mining | PubMed |
| Comparative Immunohistochemical Analysis of Clinicopathological Subgroups in Hepatocellular Carcinomas from Japan and Indonesia. | J Clin Exp Hepatol | 2024 | 38975604 | PubTator, text mining | PubMed |
| Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience. | Int J Mol Sci | 2024 | 38928458 | PubTator, text mining | PubMed |
| Integrin β3 Reprogramming Stemness in HER2-Positive Breast Cancer Cell Lines. | Biology (Basel) | 2024 | 38927308 | PubTator, text mining | PubMed |
| Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives. | Bioorg Med Chem Lett | 2024 | 38917956 | PubTator, text mining | PubMed |
| SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma. | Pharmacogenomics | 2024 | 38884945 | PubTator, text mining | PubMed |
| Expression of CD44 and SALL4 in Leukoplakia and Oral Squamous Cell Carcinoma. | J Pharm Bioallied Sci | 2024 | 38882798 | PubTator, text mining | PubMed |
| Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases. | Orphanet J Rare Dis | 2024 | 38877473 | PubTator, text mining | PubMed |
| Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration. | Sci Rep | 2024 | 38866822 | PubTator, text mining | PubMed |
| Unveiling gene regulatory networks during cellular state transitions without linkage across time points. | Sci Rep | 2024 | 38811747 | PubTator, text mining | PubMed |
| Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumours. | Biomarkers | 2024 | 38808385 | PubTator, text mining | PubMed |
| Stage IV gastric adenocarcinoma with enteroblastic differentiation with 5-year relapse-free survival after D2 gastrectomy and chemotherapy: A case report. | Surg Case Rep | 2024 | 38744791 | PubTator, text mining | PubMed |
| Prediction of novel biomarkers for gastric intestinal metaplasia and gastric adenocarcinoma using bioinformatics analysis. | Heliyon | 2024 | 38737262 | PubTator, text mining | PubMed |
| Primitive Embryonic-Type Neuroectodermal/Glandular Complexes in Testicular Germ Cell Tumors: A Mimic of Embryonic-Type Neuroectodermal Tumor. | Am J Surg Pathol | 2024 | 38712621 | PubTator, text mining | PubMed |
| Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment. | Nat Commun | 2024 | 38704377 | PubTator, text mining | PubMed |
| Is the Cis-Element CACCC-Box a Master Regulatory Element during Cardiovascular Disease? A Bioinformatics Approach from the Perspective of the Krüppel-like Family of Transcription Factors. | Life (Basel) | 2024 | 38672763 | PubTator, text mining | PubMed |
| Evaluation and Management of Testicular Cancer After Late Relapse. | Oncology (Williston Park) | 2024 | 38661513 | PubTator, text mining | PubMed |
Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers. | Am J Surg Pathol | 2024 | 38651612 | PubTator, text mining | PubMed |
| SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms. | Mol Med | 2024 | 38584262 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57167/papers?page=12